| Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions |
23 |
| Left ventricular thrombus formation in patients undergoing femoral veno-arterial extracorporeal membrane oxygenation |
12 |
| Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature |
11 |
| Extracorporeal membrane oxygenation in life-threatening massive pulmonary embolism |
11 |
| Extubation of patients undergoing extracorporeal life support. A retrospective study |
9 |
| Intracranial hemorrhage in adults on ECMO |
9 |
| Using near-infrared reflectance spectroscopy (NIRS) to assess distal-limb perfusion on venoarterial (V-A) extracorporeal membrane oxygenation (ECMO) patients with femoral cannulation |
9 |
| Pressure and flow properties of cannulae for extracorporeal membrane oxygenation I: return (arterial) cannulae |
9 |
| Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM (TM)) |
8 |
| Assessing the depth of isoflurane anaesthesia during cardiopulmonary bypass |
8 |
| Effects of sodium citrate, citric acid and lactic acid on human blood coagulation |
8 |
| Veno-arterio-venous ECMO for septic cardiomyopathy: a single-centre experience |
7 |
| Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation |
7 |
| Pressure and flow properties of cannulae for extracorporeal membrane oxygenation II: drainage (venous) cannulae |
7 |
| Vascular complications following intra-aortic balloon pump implantation: an updated review |
7 |
| Risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation: Is distal limb perfusion a mandatory approach? |
6 |
| Protracted aortic valve closure during peripheral veno-arterial extracorporeal life support: is intra-aortic balloon pump an effective solution? |
5 |
| Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation |
5 |
| Early negative fluid balance is associated with lower mortality after cardiovascular surgery |
5 |
| GSK-3 beta inhibition confers cardioprotection associated with the restoration of mitochondrial function and suppression of endoplasmic reticulum stress in sevoflurane preconditioned rats following ischemia/reperfusion injury |
5 |
| Serum levels of interleukin- interleukin- interleukin- and tumor necrosis factor-alpha, renal function biochemical parameters and clinical outcomes in pediatric cardiopulmonary bypass surgery |
5 |
| Intraoperative changes in blood lactate levels are associated with worse short-term outcomes after cardiac surgery with cardiopulmonary bypass |
5 |
| Hemoglobin trigger and approach to red blood cell transfusions during veno-venous extracorporeal membrane oxygenation: the international TRAIN-ECMO survey |
5 |
| CO2 clearance by membrane lungs |
5 |
| Shed-blood-separation and cell-saver: an integral Part of MiECC? Shed-blood-separation and its influence on the perioperative inflammatory response during coronary revascularization with minimal invasive extracorporeal circulation systems - a randomized controlled trial |
4 |
| The effect of air exposure on leucocyte and cytokine activation in an in-vitro model of cardiotomy suction |
4 |
| Evaluation of attention, perception, and stress levels of clinical cardiovascular perfusionists during cardiac operations: a pilot study |
4 |
| Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery |
4 |
| Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial |
4 |
| Chronic venous insufficiency: a new concept to understand pathophysiology at the microvascular level-a pilot study |
4 |
| Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants |
4 |
| Echocardiography in extracorporeal life support: A key player in procedural guidance, tailoring and monitoring |
4 |
| Brain perfusion evaluated by regional tissue oxygenation as a possible quality indicator of ongoing cardiopulmonary resuscitation. An experimental porcine cardiac arrest study |
3 |
| Effect of pump type on outcomes in neonates with congenital diaphragmatic hernia requiring ECMO |
3 |
| The Norwood Stage 1 procedure-conduct of perfusion: 2017 Survey results from NPC-QIC member institutions |
3 |
| Vascular anatomical considerations and clinical decision making during insertion of the AvalonA (R) Elite Dual Lumen single-site veno-venous ECMO cannula in children weighing less than 20 kg |
3 |
| The influence of ultrafiltration on red blood cell transfusion during cardiopulmonary bypass |
3 |
| Safety of nitric oxide added to the ECMO circuit: a pilot study in children |
3 |
| Plasma-Lyte 148 vs. Hartmann's solution for cardiopulmonary bypass pump prime: a prospective double-blind randomized trial |
3 |
| Continuous cytokine haemoadsorption incorporated into a venoarterial ECMO circuit for the management of postcardiotomy cardiogenic and septic shock - a case report |
3 |
| Addressing the challenges of ECMO simulation |
3 |
| Differential hypoxemia during venoarterial extracorporeal membrane oxygenation |
3 |
| Learning curve for multidisciplinary team setup in veno-venous extracorporeal membrane oxygenation for acute respiratory failure |
3 |
| Effect of ex vivo extracorporeal membrane oxygenation flow dynamics on immune response |
3 |
| Mesenchymal stem cells may ameliorate inflammation in an ex vivo model of extracorporeal membrane oxygenation |
3 |
| Weaning adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation by pump-controlled retrograde trial off |
3 |
| A retrospective analysis of the mixed venous oxygen saturation as the target for systemic blood flow control during cardiopulmonary bypass |
3 |
| The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass |
3 |
| Venovenous extracorporeal life support in patients with HIV infection and Pneumocystis jirovecii pneumonia |
3 |
| Prognostic impact of blood product transfusion in VA and VV ECMO |
3 |
